6.8400
19-February-25 11:28:30
15 minutes delayed
Stocks
-0.2900
-4.07%
Today's range
6.8300 - 7.0700
ISIN
FR0012127173
Source
Cboe
OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer
10 Apr 2024 12:00:00 By Nasdaq GlobeNewswire
OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1 in Journal of Immunology
02 Apr 2024 01:30:00 By Nasdaq GlobeNewswire
OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update
27 Mar 2024 13:00:00 By Nasdaq GlobeNewswire